Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
IMG Partners with Riviera Travel to Provide Travel Insurance to U.S. Travelers 2025-10-28 21:00
SI GROUP OPENS NEW INNOVATION CENTER 2025-10-28 20:30
Sisram Medical Delivers Strong Third-Quarter 2025 Performance with Robust Momentum Across Key Markets and Core Businesses 2025-10-28 20:29
South Korea's Leading Hair Loss Treatment Company, AESMED Co., Ltd., to Participate in Cosmoprof Asia Hong Kong 2025 2025-10-28 19:37
Ping An Reports Significant Improvements in Operating Profit in 9M 2025, Life & Health NBV Robustly Increases 46.2% YoY 2025-10-28 18:02
Xinhua Silk Road: Innovation, tradition deeply integrated on TCM trade fair in China's Zhangshu City 2025-10-28 16:31
Xinhua Silk Road: Traditional Chinese medicine showcases its timeless magic 2025-10-28 11:38
Standard Foods Announces Strategic Partnership and Investment in Hello Health to Strengthen the Bridge Between Digital Health and Nutrition in Southeast Asia. 2025-10-28 10:00
Alphamab Oncology Announces Biparatopic HER2-targeting ADC JSKN003 Was Granted Fast Track Designation by FDA for the Treatment of PROC 2025-10-28 09:46
JSBio Strengthens Commitment to Power Cellular Agriculture Commercialization 2025-10-28 09:00
Onward Therapeutics Exercises Exclusive Option and Signs Worldwide License Agreement with Institut du Cancer de Montpellier for Novel Onco-Metabolism Program 2025-10-28 08:00
Nippon Shinyaku Selects LifeSphere® Safety 2025-10-28 07:00
Vietnam Healthcare Summit 2025: Powering Transformation of Vietnam's Healthcare Landscape Through Innovation and Investment 2025-10-28 01:31
The WEMP Foundation and Rafa Nadal Foundation are joining together to Support Total Wellbeing of Children and Youth through Play 2025-10-27 22:13
Shanton Pharma Completes EOP2 Meeting with US FDA for Refractory Gout Program 2025-10-27 21:00
Kolmar Korea Selected for Government-Led 'AI Factory' Initiative -- Driving Innovation in K-Beauty Manufacturing 2025-10-27 20:30
China's NMPA Grants Breakthrough Therapy Designation for Anti-CTLA-4 Antibody Candidate Gotistobart (BNT316/ONC-392) 2025-10-27 19:00
Ascletis to Present Study Results of ASC30 Oral Tablet, ASC30 Injection, and Combination of ASC31 and ASC47 at ObesityWeek® 2025 2025-10-27 18:00
Raffles Medical Group Partners Gene Solutions to Expand Access to Global Cancer Clinical Trials 2025-10-27 13:22
KLN Named Exclusive Distributor for Siemens Healthineers 2025-10-27 12:00
1 14 15 16 17 18 918